Gastrointestinal Stromal Tumor (GIST)
Videos
Overview
Gastrointestinal Stromal Tumors (GISTs) are rare tumors that arise from the interstitial cells of Cajal—specialized cells that help regulate digestive movement. GISTs most commonly occur in the stomach or small intestine and may be discovered incidentally or after symptoms such as abdominal pain, bleeding, or early satiety. Many GISTs are driven by mutations in the KIT or PDGFRA genes, which guide treatment options. Management typically includes surgical removal and, in some cases, targeted therapy such as imatinib.
Causes
Most GISTs are caused by mutations in the KIT or PDGFRA genes. These mutations occur spontaneously and are not usually inherited. Rare hereditary syndromes may also increase risk.
Risk Factors
Risk factors include older age, family history of GIST, certain genetic syndromes, and prior radiation exposure. Most cases occur without identifiable risk factors.
How GIST Affects the Body
As the tumor grows, it may cause bleeding, obstruction, or pressure on nearby organs. Some GISTs spread to the liver or peritoneum. Tumor behavior depends on size, location, and mutation type.
Complications
Complications include gastrointestinal bleeding, obstruction, anemia, abdominal pain, and spread to distant organs.
Symptoms & Signs
Symptoms include abdominal pain, early satiety, nausea, vomiting, fatigue, black stools, or unexplained weight loss. Some patients have no symptoms until the tumor is large.
Diagnosis
Diagnosis includes CT scan, MRI, endoscopy, endoscopic ultrasound (EUS), and biopsy with immunohistochemistry (KIT/CD117). Genetic testing helps guide targeted therapy.
Differential Diagnosis
Includes gastric cancer, leiomyoma, lymphoma, pancreatic tumors, and benign submucosal masses.
Lifestyle Modifications
Patients may benefit from eating smaller meals, managing reflux, avoiding NSAIDs if bleeding risk is present, and maintaining a healthy weight. These changes support overall health but do not replace medical treatment.
Treatment Options
Treatment depends on tumor size, location, and mutation type. Options include minimally invasive surgical removal, targeted therapy (imatinib, sunitinib, regorafenib), and surveillance for very small, low‑risk tumors. A multidisciplinary approach is essential.
When to See a Doctor
Seek evaluation if you experience abdominal pain, bleeding, early satiety, or unexplained weight loss.
When to Seek Treatment
Treatment is recommended when imaging or biopsy confirms GIST or when symptoms suggest bleeding or obstruction.
Long-Term Outlook
Long‑term outcomes vary based on risk category and response to therapy. Regular imaging and follow‑up are essential to monitor for recurrence.
Prognosis
Prognosis depends on tumor size, mitotic rate, mutation type, and completeness of surgical removal. Targeted therapy has significantly improved outcomes for advanced GIST.
Why Choose Dr. de la Cruz‑Muñoz
Dr. Nestor de la Cruz‑Muñoz provides expert evaluation and minimally invasive surgical management of GIST, offering precise tumor removal, reduced recovery time, and excellent long‑term outcomes.
